Hepatic Overexpression of Lysophospholipid Acyltransferase LPLAT14 / MBOAT1 Ameliorates Mild Liver Injury During Early High‐Fat Diet Feeding
FASEB BioAdvances · 2026-11 · 8 (11)
DOI: 10.1096/fba.2026-00165 ↗Kurz gefasst
Fachartikel in der Zeitschrift FASEB BioAdvances, online erschienen am 02.11.2026. Verfasst von Sho Hori und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences The University of Osaka Osaka Japan. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metabolic dysfunction‐associated steatotic liver disease (MASLD) encompasses a spectrum of conditions progressing from simple steatosis to severe steatohepatitis. During this progression, liver injury associated with lipotoxicity and altered membrane phospholipid homeostasis is thought to contribute to disease aggravation. Although lysophospholipid acyltransferases (LPLATs) regulate membrane lipid remodeling and contribute to cellular integrity, the physiological roles of several LPLATs have only partially been characterized, and the in vivo functions of LPLAT14 remain largely unknown. Here, we investigated the effects of hepatic overexpression of LPLAT14 on high‐fat diet (HFD)‐induced metabolic disorders and mild liver injury in mice using an improved adenovirus (Ad) vector. Hepatic LPLAT14 overexpression did not significantly alter body weight, systemic glucose tolerance, or hepatic lipid accumulation. Targeted lipidomics revealed that LPLAT14 overexpression selectively significantly increased oleic acid (OA)‐containing phosphatidylserine (PS) species in the liver, suggesting selective incorporation of OA into lysophosphatidylserine. This specific lipidomic remodeling significantly attenuated mild liver injury during early HFD feeding, as evidenced by reduced serum alanine aminotransferase levels at 2 weeks after Ad‐LPLAT14 treatment. However, this hepatoprotective effect was not observed in the later phase (8 weeks), when severe lipid accumulation had developed, suggesting that LPLAT14 primarily attenuates mild liver injury during early HFD feeding. Collectively, our findings suggest that LPLAT14‐mediated enrichment of OA‐containing PS attenuates mild liver injury during early HFD feeding, possibly through protection against early cellular stress.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences The University of Osaka Osaka Japan.
- Laboratory of Biochemistry and Molecular Biology, School of Pharmaceutical Sciences The University of Osaka Osaka Japan.
- Lipidome Lab Co., Ltd. Akita Japan.
- Department of Lipid Life Science, National Institute of Global Health and Medicine Japan Institute for Health Security Tokyo Japan.
- Department of Medical Lipid Science, Graduate School of Medicine The University of Tokyo Tokyo Japan.
- Global Center for Medical Engineering and Informatics The University of Osaka Osaka Japan.
ORCID-Profile: Kahori Shimizu, Hideo Shindou, Hiroyuki Mizuguchi
Zitieren
APA
Hori, S., Shimizu, K., Kikuchi, T., Miyata, H., Hase, H., Nakanishi, H., Shindou, H., & Mizuguchi, H. (2026). Hepatic Overexpression of Lysophospholipid Acyltransferase LPLAT14 / MBOAT1 Ameliorates Mild Liver Injury During Early High‐Fat Diet Feeding. FASEB BioAdvances, 8(11). https://doi.org/10.1096/fba.2026-00165
Vancouver
Hori S, Shimizu K, Kikuchi T, Miyata H, Hase H, Nakanishi H, et al. Hepatic Overexpression of Lysophospholipid Acyltransferase LPLAT14 / MBOAT1 Ameliorates Mild Liver Injury During Early High‐Fat Diet Feeding. FASEB BioAdvances. 2026;8(11). doi:10.1096/fba.2026-00165
BibTeX
@article{Hori2026,
author = {Hori, Sho and Shimizu, Kahori and Kikuchi, Taiga and Miyata, Hajime and Hase, Hiroaki and Nakanishi, Hiroki and Shindou, Hideo and Mizuguchi, Hiroyuki},
title = {Hepatic Overexpression of Lysophospholipid Acyltransferase LPLAT14 / MBOAT1 Ameliorates Mild Liver Injury During Early High‐Fat Diet Feeding},
journal = {FASEB BioAdvances},
year = {2026},
volume = {8},
number = {11},
doi = {10.1096/fba.2026-00165}
}
EUVIMED